74 related articles for article (PubMed ID: 21552947)
1. In-vivo effect of somatostatin analog, lanreotide, and/or grp antagonist, bim-26226, on the growth of colon-cancer peritoneal carcinomatosis in the rat.
Gouyon B; Reyldesmars F; Leromancer M; Pigeon C; Lewin M; Lehy T
Int J Oncol; 1995 Nov; 7(5):1167-73. PubMed ID: 21552947
[TBL] [Abstract][Full Text] [Related]
2. Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
Damgé C; Hajri A
Eur J Pharmacol; 1998 Apr; 347(1):77-86. PubMed ID: 9650851
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G
Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623
[TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogue RC-160 inhibits the growth of transplanted colon cancer in rats.
Qin Y; Schally AV; Willems G
Int J Cancer; 1991 Mar; 47(5):765-70. PubMed ID: 1672306
[TBL] [Abstract][Full Text] [Related]
8. Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats.
Ruszniewski P; Lehy T; Reyl-Desmars F; Le Roux S; Lewin MJ
Regul Pept; 1993 Feb; 43(3):141-7. PubMed ID: 8441819
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
12. Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
Ali M; Gawin AZ; Baraniuk JN
J Pharmacol Exp Ther; 1996 Mar; 276(3):1266-71. PubMed ID: 8786559
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
14. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
[TBL] [Abstract][Full Text] [Related]
15. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.
Mariani P; Blumberg J; Landau A; Lebrun-Jezekova D; Botton E; Beatrix O; Mayeur D; Herve R; Maisonobe P; Chauvenet L
J Clin Oncol; 2012 Dec; 30(35):4337-43. PubMed ID: 23109694
[TBL] [Abstract][Full Text] [Related]
17. Regulation of prostate cancer cell proliferation by somatostatin receptor activation.
Ruscica M; Arvigo M; Gatto F; Dozio E; Feltrin D; Culler MD; Minuto F; Motta M; Ferone D; Magni P
Mol Cell Endocrinol; 2010 Feb; 315(1-2):254-62. PubMed ID: 19932151
[TBL] [Abstract][Full Text] [Related]
18. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.
Favoulet P; Benoit L; Osmak L; Polycarpe E; Esquis P; Duvillard C; Guiu B; Rat P; Favre JP; Chauffert B
World J Surg; 2004 May; 28(5):451-6. PubMed ID: 15085402
[TBL] [Abstract][Full Text] [Related]
19. Bombesin-like peptides stimulate somatostatin release from rat fundic D cells in primary culture.
Schaffer K; Herrmuth H; Mueller J; Coy DH; Wong HC; Walsh JH; Classen M; Schusdziarra V; Schepp W
Am J Physiol; 1997 Sep; 273(3 Pt 1):G686-95. PubMed ID: 9316473
[TBL] [Abstract][Full Text] [Related]
20. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]